ArticleOncotarget2017

Targeting protein homeostasis with nelfinavir/salinomycin dual therapy effectively induces death of mTORC1 hyperactive cells.

Elaine A Dunlop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.